San Francisco, January 10, 2007 – NeuroInsights announced that Orexigen Therapeutics (NASDAQ: OREX) and Questcor Pharmaceuticals (AMEX: QSC) have been added to the NASDAQ® NeuroInsights® Neurotech Index (NASDAQ: NERV). The NASDAQ NeuroInsights Neurotech Index is the first index designed to track the performance of leading neurotechnology companies which are listed and actively traded on one of the three major U.S. stock exchanges.
